JPMorgan's top biopharma picks for 2025
found
The Nasdaq Biotechnology Index (NBI) has gained 6.5% this year, outpacing gains from both the S&P 500 and tech-heavy Nasdaq Composite.
NBI
since
auto-detected in 1 stories
73 days ago
page 1 of 1